Post Partum Hemorrhage Clinical Trial
Official title:
New Surgical Technique To Control Postpartum Hemorrhage Due To Placenta Accreta
NCT number | NCT03241849 |
Other study ID # | STPPGE |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2017 |
Est. completion date | February 1, 2020 |
Verified date | June 2020 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Placenta accreta is an obstetrical complication where the placenta becomes firmly adherent to
the uterine wall. Placenta accreta can lead to considerable maternal morbidity and mortality
due to hemorrhage, infection, or other surgical complications such as those resulting from
hysterectomy. Retained placenta accreta is usually a rare condition, but its prevalence is
increasing due to the rise in the rate of deliveries by Cesarean section.
Placenta accreta is a potentially life-threatening obstetric condition that requires a
multidisciplinary approach to management. The incidence of placenta accreta has increased and
seems to parallel the increasing cesarean delivery rate. Women at greatest risk of placenta
accreta are those who have myometrial damage caused by a previous cesarean delivery with
either an anterior or posterior placenta previa overlying the uterine scar. Diagnosis of
placenta accreta before delivery allows multidisciplinary planning in an attempt to minimize
potential maternal or neonatal morbidity and mortality.
Status | Completed |
Enrollment | 110 |
Est. completion date | February 1, 2020 |
Est. primary completion date | January 1, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility |
Inclusion Criteria: 1. Estimated gestational age between 34 -40 weeks . 2. Presence of total or focal parts of placenta accreta "morbidly adherent placenta" . 3. Cases with mild vaginal bleeding or not having any vaginal bleeding Exclusion Criteria: 1. Severe attack of bleeding require an immediate intervention. 2. Associated with placental abruption 3. Patients with known bleeding disorders or on anticoagulant therapy. 4. Preoperative decision to do peripartum hysterectomy. |
Country | Name | City | State |
---|---|---|---|
Egypt | Women Health Hospital - Assiut university | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Amount of blood loss (mL) | 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03680339 -
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
|
Phase 4 | |
Completed |
NCT03693599 -
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
|
Phase 4 | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Recruiting |
NCT02306733 -
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
|
Phase 3 | |
Completed |
NCT01866241 -
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT01236482 -
Oxytocin in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Enrolling by invitation |
NCT06255496 -
QStat Cartridge in Obstetric Patients
|
||
Recruiting |
NCT04401839 -
Amr Maneuver for Prevention of Postpartum Hemorrhage
|
N/A | |
Recruiting |
NCT06219538 -
DAISY Uterine Drain Device Evaluation
|
N/A | |
Not yet recruiting |
NCT06333340 -
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
|
N/A | |
Completed |
NCT01863706 -
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
|
Phase 1 | |
Completed |
NCT04723979 -
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
|
||
Terminated |
NCT04277962 -
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
|
N/A | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT03117647 -
Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage
|
N/A | |
Active, not recruiting |
NCT03069859 -
Use of TXA to Prevent Postpartum Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT03891082 -
A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section
|
N/A | |
Not yet recruiting |
NCT03463070 -
Misoprostol Before and After Cesarean Section
|
Phase 3 | |
Recruiting |
NCT05532215 -
Sublingual Misoprostol in Reduction of Caesarean Blood Loss
|
N/A |